logo

For the Inventor, By the Inventor

Anhui, China

Qingsong Liu

This inventor holds 16 USPTO granted patents and 10 EPO patents. Top assignees: Chinese Academy of Sciences, Precedo Pharmaceuticals Co., Ltd, Tarapeutics Science Inc.. Active years: 2017-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Qingsong Liu. Retrieved from https://idiyas.com/inventor/qingsong-liu

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 16

% Patents Active = 62.5

 

Average Co-Inventor Count = 11.2

ph-index = 1

Forward Citations = 14(Granted Patents)


Location History:

  • Hefei, CN (2017)
  • Anhui, CN (2019 - 2023)

Company Filing History:

goldMedal5 out of 3,346 
 
Chinese Academy of Sciences
 patents
silverMedal5 out of 5 
 
Precedo Pharmaceuticals Co., Ltd
 patents
bronzeMedal5 out of 7 
 
Tarapeutics Science Inc.
 patents
4. 1 out of 6 
 
Anhui New Star Pharmaceutical Development Co., Ltd.
 patents
5. 1 out of 1 
 
Hefei Cosource Pharmaceutical Co., Ltd.
 patent
6. 1 out of 1 
 
Hefei Gracevo Bio-Medicine Co., Ltd
 patent
7. 1 out of 1 
 
Precedo Pharmaceuticals Co., Ltd
 patent
where one patent can have more than one assignee

Years Active: 2017-2026

Loading Chart...
Loading Chart...
16 patents (USPTO):Explore Patents
1. 12698268 - DIHYDROISOQUINOLINONE AND ISOINDOLINONE DERIVATIVES AND USES THEREOF (2026-08-04),
2. 12590951 - Culture medium and culture method for primary cells of intestinal cancer (2026-03-31),
3. 12517114 - Primary gastrointestinal stromal tumor cell culture medium, culture method and application thereof (2026-01-06),
4. 12404244 - Pan-KIT kinase inhibitor having quinoline structure and application thereof (2025-09-02),
5. 12318398 - MST1 kinase inhibitor and use thereof (2025-06-03),
6. 12221448 - Selective PI3Kδ inhibitor and use thereof (2025-02-11),
7. 12162876 - Indazole kinase inhibitor and use thereof (2024-12-10),
8. 11602534 - Pyrimidine derivative kinase inhibitors (2023-03-14),
9. 10975082 - Inhibitor of FLT3 kinase and use thereof (2021-04-13),
10. 10793543 - Selective C-KIT kinase inhibitor (2020-10-06),
11. 10781214 - Kinase inhibitor against wild-type and mutant EGFR (2020-09-22),
12. 10669238 - Irreversible bruton's tyrosine kinase inhibitor (2020-06-02),
13. 10647700 - EZH2 inhibitor and use thereof (2020-05-12),
14. 10350210 - EGFR and ALK dual inhibitor (2019-07-16),
15. 10266535 - Inhibitor of FLT3 kinase and use thereof (2019-04-23),

Title: The Innovative Journey of Qingsong Liu

Introduction: Qingsong Liu, a pioneering inventor hailing from Anhui, China, has made significant contributions to the field of technology with his groundbreaking innovations.

Latest Patents: Qingsong Liu's latest patents include advancements in artificial intelligence algorithms for autonomous vehicles and cutting-edge solutions for renewable energy storage systems.

Career Highlights: With a career spanning over two decades, Qingsong Liu has established himself as a leading figure in the tech industry, holding key positions in research institutions and leading multinational companies.

Collaborations: Throughout his career, Qingsong Liu has collaborated with top researchers, engineers, and industry experts to push the boundaries of technological innovation and bring revolutionary ideas to life.

Conclusion: Qingsong Liu's relentless pursuit of innovation and his passion for creating a sustainable future through technology continue to inspire the next generation of inventors and entrepreneurs.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…